Page last updated: 2024-08-21

2,6-dichloro-4-nitrophenol and HIV Coinfection

2,6-dichloro-4-nitrophenol has been researched along with HIV Coinfection in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Collier, AC; Delle Fratte, R; Eguchi, M; Ho, RJY; Melvin, AJ; Perazzolo, S; Stephen, ZR; Xu, X1

Other Studies

1 other study(ies) available for 2,6-dichloro-4-nitrophenol and HIV Coinfection

ArticleYear
A novel formulation enabled transformation of 3-HIV drugs tenofovir-lamivudine-dolutegravir from short-acting to long-acting all-in-one injectable.
    AIDS (London, England), 2023, 11-15, Volume: 37, Issue:14

    Topics: Animals; Anti-HIV Agents; Drug Combinations; Heterocyclic Compounds, 3-Ring; HIV Infections; Lamivudine; Leukocytes, Mononuclear; Oxazines; Pharmaceutical Preparations; Pyridones; Tenofovir

2023